Intranasal Palivizumab Fails to Prevent RSV Infection in Preterm Babies Jacinthlyn Sylvia4 Jan 2024 7:00 PM ISTA recent double-blind, randomized placebo-controlled trial found that daily intranasal palivizumab, a mucosal monoclonal antibody (mAb) did not...
AstraZeneca-Sanofi Beyfortus gets nod for RSV disease prevention in infants in China Ruchika Sharma2 Jan 2024 3:06 PM ISTChina: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of...
Nirsevimab effective in preventing hospitalization for RSV associated lower RTI in infants Aditi29 Dec 2023 7:00 PM ISTRespiratory syncytial virus (RSV) is a common cause of lower respiratory tract infection in young children and infants, leading to...
Preventive therapy for RSV: AstraZeneca India gets CDSCO nod for Palivizumab injection Ruchika Sharma3 Oct 2023 2:30 PM ISTNew Delhi: AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, has announced the marketing approval from Central Drugs Standard...
Live-Attenuated RSV Vaccine Shows Immunogenicity in Children: Journal of Infectious Diseases Jacinthlyn Sylvia21 Sept 2023 10:15 AM ISTRespiratory syncytial virus (RSV) is a significant cause of lower respiratory illness (LRI) in pediatric populations. With the need for an effective...
First Vaccine for Pregnant Individuals to Prevent RSV in Infants approved by FDA Dr. Kamal Kant Kohli22 Aug 2023 12:00 PM ISTRespiratory Syncytial Virus is a highly contagious virus that causes respiratory infections in individuals of all age groups. Furthermore it is the...
AAP Recommends Nirsevimab to Protect Infants Against Severe RSV: Monoclonal Antibody Gains Traction Dr. Kamal Kant Kohli18 Aug 2023 9:45 AM ISTUSA: The American Academy of Pediatrics (AAP) has released recommendations for the use of the monoclonal antibody nirsevimab for the prevention of...
AstraZeneca gets CDSCO Panel Nod To Import, Market Palivizumab solution for injection Dr. Divya Colin17 Aug 2023 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Sanofi-AstraZeneca Beyfortus gets unanimous US CDC Advisory Committee recommendation to prevent RSV in neonates, infants Ruchika Sharma4 Aug 2023 1:09 PM ISTParis: Sanofi has recently announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization...
RSV infection during infancy tied to onset of asthma in childhood: Lancet Aditi31 July 2023 8:00 PM ISTA study published in The Lancet has found an age-dependent association between respiratory syncytial virus or RSV infection during infancy and...
FDA approves new drug to Prevent RSV in infants and very young children Dr. Kamal Kant Kohli19 July 2023 11:45 AM ISTThe U.S. Food and Drug Administration has approved The FDA approved nirsevimab (Beyfortus) for prevention of respiratory syncytial virus (RSV)-related...
GSK gets CDSCO panel Nod for Phase III Extension safety follow-up study for trial of RSVPreF3 vaccine Dr. Divya Colin12 July 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
